N2/H2 plasma surface modifications of polystyrene inhibit the adhesion of multidrug resistant bacteria  by Trentin, Danielle S. et al.
Surface & Coatings Technology 245 (2014) 84–91
Contents lists available at ScienceDirect
Surface & Coatings Technology
j ourna l homepage: www.e lsev ie r .com/ locate /sur fcoatN2/H2 plasma surface modiﬁcations of polystyrene inhibit the adhesion
of multidrug resistant bacteriaDanielle S. Trentin a,b, Fernando Bonatto c, Karine R. Zimmer b, Vanessa B. Ribeiro a, Ana Lúcia S. Antunes a,
Afonso L. Barth a,d, Gabriel V. Soares c, Cristano Krug c, Israel J.R. Baumvol c,e, Alexandre J. Macedo a,b,⁎
a Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Av. Ipiranga, 2752, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil
b Centro de Biotecnologia da Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves, 9500, 91501-970 Porto Alegre, Rio Grande do Sul, Brazil
c Instituto de Física, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves, 9500, 91509900 Porto Alegre, Rio Grande do Sul, Brazil
d Serviço de Patologia Clínica, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903 Porto Alegre, Rio Grande do Sul, Brazil
e Universidade de Caxias do Sul, Rua Francisco Getúlio Vargas, 1130, 95070-560 Caxias do Sul, Rio Grande do Sul, Brazil⁎ Corresponding author at: Faculdade de Farmácia, Univ
do Sul, Av. Ipiranga, 2752, 90610-000 Porto Alegre, Rio Gra
33086082; fax: +55 51 33087309.
E-mail address: alexandre.macedo@ufrgs.br (A.J. Mace
http://dx.doi.org/10.1016/j.surfcoat.2014.02.046
0257-8972/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 23 December 2013
Accepted in revised form 21 February 2014
Available online 2 March 2014
Keywords:
Bacterial adhesion
Multidrug resistant bacteria
Plasma treatment
Polystyrene
Surface modiﬁcationAdhesion is the ﬁrst step in bioﬁlm formation, a bacterial lifestyle characterized by antimicrobial resistance usu-
ally associated with implant infections. In this way, the modiﬁcation of material surface by plasma processing
represents an attractive strategy to understand and control bacterial–material interactions. Thiswork challenged
multidrug resistant pathogenic emerging bacteria to adhere on polystyrene submitted to radio frequency dis-
charges. We used N2 and H2 plasma to treat polystyrene surface and we evaluated, using crystal violet assay,
the ability of bacteria possessing hydrophobic or hydrophilic surfaces to adhere on the polymer, at distinct pe-
riods of shelf life. The material surface characterization was conducted using X-ray photoelectron spectroscopy
(XPS) andwater contact angle (WCA)measurements. It is shown that the two employed treatments,which differ
in duration and power applied to the plasma, are able to inhibit up to 83% Klebsiella pneumoniae adhesion in the
ﬁrst 24 h,without biocidal effect. Results fromXPS andWCAmeasurements reveal that nitrogen concentration in
excess of 8.8% or polar component of the surface energy above 15mJm−2 are sufﬁcient to produce the beneﬁcial
effects sought. The correlation with biological ﬁndings indicates that the limited adhesion of bacteria possessing
hydrophilic surface on plasma-treated surfaces may be explained in terms of electrostatic repulsion. Therefore,
this work demonstrates that the potential application of plasma surface modiﬁcation extends the possibility of
controlling the adhesion of different bacterial species and genera.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Polymers are widely used as biomaterials in prosthesis, bone
replacement implants, drug delivery, catheters and tissue engineering
[1,2]. Among them, poly(methyl methacrylate) [3], poly(ethylene
glycol) [4], polytetraﬂuoroethylene [5], and polyurethane [6] are
commonly used due to their biocompatibility, mechanical properties
and ease of molding into desirable shapes. Either in single form or as
copolymer, polystyrene (PS) has attracted considerable attention,
since the polymer presents excellent mechanical properties, side by
side with the wide availability of its precursor, the styrene monomer,
which lowers production costs [7–9]. This polymer is widely used in
cell culture applications because of its non-toxicity andhigh transparen-
cy, as indicated by the number of brand names available in research area
for this purpose. Although the use of PS as biomaterial is uncommon inersidade Federal do Rio Grande
nde do Sul, Brazil. Tel.: +55 51
do).clinical practice, polystyrene is used for medical applications in artiﬁcial
liver support and in controlled release devices [10]. Also its use is
described in wound dressing and coatings for implantable medical
devices [11] as well as in implantable medical devices for controlled
delivery of therapeutic agent [12].
Many of these materials were not originally designed for medical
applications, and were selected for such uses based solely on their
bulk properties, such as mechanical strength [13]. As a result, many
widely used biomaterials suffer from signiﬁcant drawbacks, including
the proneness to bacterial infection. When a given biomaterial is
implanted, it can become a site for bacterial adhesion, colonization,
and further formation of a multicellular structure highly resistant to
antimicrobials, named bioﬁlm [14,15]. According to the National Insti-
tutes of Health, 80% of hospital-acquired infections worldwide are
attributed to bacteria forming bioﬁlms [16]. Staphylococcus epidermidis
is known to be a pathogen involved in nosocomial infections on
medical devices [17]. Equally important are the infections caused by
Staphylococcus aureus, in which the resistance to methicillin has been
held accountable for increased hospital stays and healthcare costs
[18]. In addition, considerably important is the emergence and rapid
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Carbapenemase (KPC)-producing Enterobacteriaceae, whose infections
are associated with high mortality rates [19]. Carbapenemases are bac-
terial enzymes able to hydrolyse all β-lactam antimicrobials [20], in-
cluding carbapenems — one of the few available treatment options in
infections caused by Gram-negative bacteria. The high prevalence of
KPC-producing Enterobacteriaceae in patients who had been implanted
with artiﬁcial devices has been reported [19].
Since biomaterial infections develop following initial adhesion of the
pathogens to the material surface, this issue evidences the need for the
development of materials with anti-infective surfaces. To avoid search
for new biomaterials, management of bacterial adhesion through the
control of surface properties of materials used in themanufacture of in-
dwelling devices can be pursued. In order to obtain anti-infective prop-
erties, different approaches have been used, such as impregnation of
antibacterial molecules on the polymer surface, polymer surface engi-
neering methods, or a combination of both [21–25]. Although the use
of antimicrobials leads to anti-infective surfaces for a wide range of
pathogens, it requires relatively large amounts of chemicals, increasing
costs, and there is the possibility of leaching. Moreover, the continuous
use of antimicrobials is controversial, since it can induce the develop-
ment of bacterial resistance. Surface engineering methods have been
used to modify the surface properties of materials in different ways
[26]. Among the available strategies, plasma surface modiﬁcation
(PSM) shows advantages [27,28] such as relatively low cost, environ-
mental friendliness, applicability to diverse materials of complex
shapes, changing only surface properties and preserving favorable
bulk characteristics of materials.
Thiswork intends to be a contribution to explore the potential of the
polymer surface engineering by PSMmethods rather than the presenta-
tion of a newmodiﬁed material suitable for indwelling clinical applica-
tions. Thus, PS was modiﬁed by plasma treatments in a mixture of N2
and H2 gases and seven bacteria, presenting remarkable resistance to
antimicrobials and distinct bacterial surface hydrophobicity index,
were tested with respect to adhesion on the treated surfaces. We used
two well-known reference strains, S. epidermidis ATCC 35984 and
S. aureus MRSA ATCC 33591, and also fresh clinical isolates of
S. epidermidis and KPC-producing Enterobacteriaceae in order to chal-
lenge the plasma-treated-PS to multidrug resistant pathogenic emerg-
ing strains. The characterization of material and bacterial surfaces was
performed, and ﬁndings thereof were associated with biological assays.
2. Material and methods
2.1. Polystyrene substrate
Standard sterile 96-well PS ﬂat bottom microtiter plates (Costar
3599) were purchased from Corning, Inc. (NY, USA).
2.2. Bacterial strains and culture conditions
In this study we focused on multidrug resistant bacteria, regarding
the extreme clinical importance of thesemicroorganisms. All the evalu-
ated strainswere previously identiﬁed through conventional phenotyp-
icmethodology [29,30] and further their identiﬁcationswere conﬁrmed
usingMicroScanWalk-Away (Dade Behring, USA) or Vitek (bioMérieux,
USA), as automated systems. The presence of blaKPC gene, responsible
for carbapenemase enzyme production, was conﬁrmed by the gold
standard polymerase chain reaction (PCR) technique using speciﬁc
primers, as previously described [31].
All clinical isolates were collected from two hospitals located
in Porto Alegre, Brazil. As Gram negative bacteria, we studied
K. pneumoniae (isolate 174), Serratia marcescens (isolate 177) and
Enterobacter cloacae (isolate 182), which are KPC-producing strains
(blaKPC gene positive). As Gram positive bacterium, we used
S. epidermidis (isolates 122 and 167b). Two reference strains wereincluded: S. epidermidis ATCC 35984 and the methicillin-resistant
S. aureus (MRSA) ATCC 33591. They were grown in Mueller Hinton
agar (Oxoid Ltd., England) overnight at 37 °C and a bacterial suspension
(3 × 108 CFU mL−1) in 0.9% NaCl was used in the assays. Minimum in-
hibitory concentration (MIC) was established according to the broth
microdilutionmethod for different drugs, in order to assess the bacterial
susceptibility proﬁle [32] (Table 1).
2.3. Microbial surface hydrophobicity index
Surface hydrophobicity of bacterial strains was determined using
the microbial adhesion to hydrocarbon (MATH) test [33]. The bacterial
suspension was cultured with tryptone soya broth (TSB) (Oxoid Ltd.,
England) during 24h at 37 °C. The cultureswerewashedwith sterile sa-
line solution and cells were harvested by centrifugation. The suspen-
sions were adjusted to an absorbance (Ai) of about 0.3 at 600 nm
(Spectramax M2e Multimode Microplate Reader, Molecular Devices,
USA). Toluene (500 μL) was added to 3 mL of each adjusted bacterial
suspension and mixed. The new absorbances of aqueous phase (Af)
were measured after phase separation. The hydrophobicity index
(HPBI) was expressed as:
Ai−Af
 
=Ai  100% :
Bacterial strains with an HPBI greater than 70% were classiﬁed as
hydrophobic while strains with an HPBI lower than 70% were classiﬁed
as hydrophilic [33].
2.4. Plasma surface modiﬁcation
The 96-well PS samples were inserted in a vacuum chamber that
was pumped down to a pressure of 2 × 10−2 mbar. The chamber was
then pressurized to 1.3 mbar with a mixture containing 24 mol% H2
and 76 mol% N2 (purity N 99.999%). Pumping was maintained and the
pressure was kept by ﬂowing gas continuously into the chamber.
A radio frequency power source (13.56 MHz) was used to generate
the plasma. In order to minimize thermal effects, the sample holder
was monitored; it stayed below two thirds of the glass transition tem-
perature of PS (95 °C) throughout the treatment period. After the treat-
ment, samples were removed from the vacuum chamber and
immediately sealed in a sterile package that was not opened until sur-
face characterization or biological assay (see below). The effects of
PSMwere investigated stipulating twodifferent times andpower condi-
tions, namely: treatments 1 (300 s at 125W) and 2 (60 s at 75W),while
all other parameterswere kept constant. The effect of shelf lifewas eval-
uated by analyzing samples 15 and 30 days after plasma treatments,
simulating the storage of the plasma-treated material. The control for
plasma treatmentswas performed by exposing polystyrenemicroplates
to the N2/H2 gas mixture without igniting the plasma.
2.5. Surface characterization
PS samples were characterized before and after the plasma treat-
ment using X-ray photoelectron spectroscopy (XPS) and water contact
angle (WCA) measurements. Surface concentrations of C, N, and O
were determined by XPS in a setup calibrated using UK's National Phys-
ical Laboratory (NPL) referencematerials and software. Chemical speci-
ation of the C 1s signal was achieved with an Omicron SPHERA
spectrometer at a pass energy of 5 eV using Mg Kα radiation
(1253.6 eV). Spectral ﬁtting was performed using CASA XPS software.
Contact angle measurements were carried out using the sessile drop
technique and doubly deionized water. The drop was observed directly
with an Olympus BX-41 microscope objective lens and images were
digitally captured using a 1.4 megapixel CCD camera. The reported
water contact angles are means of more than ﬁve measurements
Table 1
Bacterial strains: site of isolation, ability to adhere and to produce bioﬁlm on PS surface, HPBI and antimicrobial susceptibility proﬁle.
Isolate Bacterial
identiﬁcation
Ability to adhere
and form bioﬁlm
HPBI
(%)
Clinical
specimen
MIC (μg mL−1)/susceptibility proﬁle (CLSI 2013)a
IMIb MERc ERTd CAZe PIPf CIPg AKh OXAi VANj RIFk GENl ERIm
K. pneumoniae 174 (KPC) Moderate 24 Blood 64/R 32/R 64/R 64/R 256/R 64/R 16/S – – – – –
S. aureus ATCC 33591 Strong 33 Standard
strain
– – – – – – – 128/R 0.5/S 2/I 0.5/S 1/I
S. marcescens 177 (KPC) Strong 42 Respiratory
tract
8/R 8/R 64/R 4/S 128/R 64/R 32/I – – – – –
E. cloacae 182 (KPC) Strong 55 Urine 8/R 4/R 8/R N256/R 128/R 64/R 2/S – – – – –
S. epidermidis ATCC 35984 Strong 77 Standard
strain
– – – – – – – ≥128/R 1/S 0.125/S ≥64/R 1024/R
S. epidermidis 122 Strong 79 Central
venous catheter
– – – – – – – 128/R 2/S 0.75/S 0.25/S 2048/R
S. epidermidis 167b Strong 84 Central
venous catheter
– – – – – – – 0.5/R 1/S 0.125/S 0.125/S 1024/R
S = susceptible; I = intermediate; R = resistant; – = not determined.
a Breakpoints CLSI 2013: IMI/MER (S ≤ 1; I = 2; R ≥ 4); ERT (S ≤ 0,5; I = 1; R ≥ 2); CAZ (S ≤ 4; I = 8; R ≥ 16); PIP (S ≤ 16/4; I = 32–64/4; R ≥ 128/4); CIP (S ≤ 1; I = 2; R ≥ 4);
AK (S ≤ 16; I = 32; R ≥ 64); OXA for S. aureus (S ≤ 2; R ≥ 4) and for S. epidermidis (S ≤ 0.25; R ≥ 0.5); VAN for S. aureus (S ≤ 2; I = 4–8; R ≥ 16) and for S. epidermidis (S ≤ 4;
I = 8–16; R ≥ 32); RIF (S ≤ 1; I = 2; R ≥ 4); GEN (S ≤ 4; I = 8; R ≥ 16); ERI (S ≤ 0.5; I = 1–4; R ≥ 8).
b Imipenem.
c Meropenem.
d Ertapenem.
e Ceftazidime.
f Piperacillin-tazobactam.
g Ciproﬂoxacin.
h Amikacin.
i Oxacillin.
j Vancomicyn.
k Rifampicin.
l Gentamicin.
m Erythromycin.
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sive components of the surface free energy were obtained using the
Owens–Wendt method [34] from contact angle measurements with
water and diiodomethane. AFM images where acquired in intermittent
contact mode using an extended multi-mode Digital Instruments
Nanoscope III microscope equippedwith scanner “E” and a single canti-
lever, arrow-type probe of resonance frequency 286 kHz. Effects caused
by the rounding of the tipwere corrected using a standard sample of sil-
iconwith 5 × 5 μm2wells, equally spaced by 5 μm.AFM imageswere an-
alyzed using WSxM 5.0 SPM Develop package [35]. The control for
plasma treatmentswasperformed by exposure polystyrenemicroplates
to the N2/H2 gas mixture without plasma discharge.
2.6. Bacterial adhesion assay
After plasma treatments, PS microtiter plates were directly used as
substrates in bacterial adhesion assay following a modiﬁed described
protocol [36]. The adhesion veriﬁed for each strain to the control micro-
plate (plate that had been submitted to the gas mixture without plasma
discharge) was considered 100% bacterial adhesion. In eachwell, 100 μL
of the bacterial suspension and 100 μL of TSB were added. Sterility con-
trol consisted of 200 μL of TSB. Following the incubation period (37 °C
for 24 h) the content of the wells was removed and the wells were
washed. The remaining attached bacteria were heat-ﬁxed (60 °C, 1 h)
and stained with crystal violet. The dye was resuspended with DMSO
(Sigma-Aldrich Co., USA) and absorbance was measured at 570 nm.
Using this assay, each strain was categorized regarding its ability to ad-
here and to produce bioﬁlm on the untreated PS, as previously de-
scribed [37].
2.7. Bacterial growth assay
To assess if the plasma treatments affect bacterial growth, two as-
says were performed: optical absorption at 600 nm (OD600) and cell vi-
ability (resazurin indicator). OD600 was measured immediately beforeand after incubation as described in the Bacterial adhesion assay section.
The difference between the ﬁnal and initial absorbances was taken as a
measure of bacterial growth. To evaluate cell viability, we took the con-
tents of wells after incubation in the bacterial adhesion assay and trans-
ferred to another standard sterile 96-well PS, to which 25 μL of a
resazurin solution (0.1mgmL−1)was added. The plateswere incubated
(2 h at 37 °C) and assessed visually: shades of blue indicated non-viable
cells and shades of pink indicated viable cells [38]. The bacterial growth
obtained for each strain by using the control microplate (plate that had
been submitted to the gasmixture without plasma discharge) was con-
sidered 100% bacterial growth. Also, appropriate antimicrobial agents
were used as positive control for bacterial growth.
2.8. Statistical analysis
Bacterial adhesion and growth by OD600 measurements are repre-
sented as percentage means ± standard deviation for each bacterial
strain (n= 3). Values higher than 100% represent a stimulation of bac-
terial adhesion or growth in comparison to the untreated samples. Dif-
ferences were analyzed by one-way ANOVA followed by the Tukey test,
and p ≤ 0.05 was considered to be signiﬁcant (SPSS 10.0 Software).
3. Results
3.1. Bacterial strain features
Bacterial strains used in this study presented a remarkable resistance
proﬁle to antimicrobials according to the MIC determinations (Table 1).
All evaluated bacteria were able to adhere and developed bioﬁlm on PS.
K. pneumoniae (174) demonstrated moderate capability, while all other
strains presented a strong capability to adhere and to form bioﬁlm on
PS, based on the described classiﬁcation scheme [37] (Table 1). Bacterial
hydrophobicity (HPBI) varied signiﬁcantly among strains. An HPBI
higher than 70% was observed for all S. epidermidis strains, which
were classiﬁed as hydrophobic bacteria and an HPBI lower than 70%
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siﬁed as hydrophilic bacteria (Table 1), according to the categorization
method previously proposed [33].
3.2. Bacterial adhesion and growth on PS surfaces
Adhesion on PS and bacterial growth as a function of N2/H2 plasma
treatments is shown in Figs. 1 and 2, respectively. Statistical analysis in-
dicates that the two treatments tested are equivalent regarding bacteri-
al adhesion and growth. The adhesion of K. pneumoniae 174, S. aureus
ATCC 33591, S. marcescens 177 and E. cloacae 182 was signiﬁcantly
inhibited after plasma treatments when compared to untreated con-
trols.K. pneumoniaewas the pathogenmore susceptible to plasma treat-
ments (up to 83% adhesion inhibition), followed by S. marcescens,
S. aureus and E. cloacae (up to 77, 65 and 48% of adhesion inhibition, re-
spectively). These rates were maintained even after 15 days of shelf life
of PS samples. However, the adhesion prevention observed up to
15 days was considerably diminished after 30 days for the Gram-
negative strains, in particular K. pneumoniae and E. cloacae, which
reached almost 90% of their original attachment capability. Concerning
S. epidermidis strains, neither treatment effectively prevented the bacte-
rial adhesion.
Plasma treatments did not interfere with bacterial growth for any of
the studied strains, as judged from OD600 measurements (Fig. 2) and
conﬁrmed by the resazurin assay (data not shown).
3.3. Surface composition
Fig. 3 shows C 1s XPS spectra from pristine and plasma-treated PS.
Spectra from the treated samples were highly asymmetric, indicating
a variety of chemical moieties. Bonding conﬁguration was evaluated
by peak-ﬁtting the C 1s envelopes. Within the resolution of the mea-
surements, ﬁve peaks of equal width at half maximum were ﬁtted.
Based on the NIST X-ray Photoelectron Spectroscopy Database [39],
the component peaks used in this work were assigned as follows:
C\C: 285 eV; C\N: +0.9 eV; C\O/C_N: +1.5 eV; C_O: +2.9 eV;
and N\C_O: +4.2 eV.
XPS revealed the overall surface composition of untreated PS as
87 at.% C and 13 at.%O; the technique does not detect hydrogen. The rel-
atively high amount of oxygen can be understood based on the high sur-
face sensitivity of XPS (analysis is restricted to less than 10 nm at the
sample surface); on the absorption of oxygen resulting in surface termi-
nation such as\OH; and on the adsorption of H2O. Fig. 4 shows that just
after plasma treatments, the samples incorporated 13 and 11 at.% N, re-
spectively for treatments 1 and 2. While signiﬁcant amounts of oxygen
were still detectable, its abundance fell to about half the original value.
In fact, nitrogen ion bombardment during plasma treatment is expected
to remove essentially all the oxygen originally at the PS surface. The ox-
ygen detected after treatments should originatemostly from reaction of
the freshly treated surface withwater vapor in the atmosphere, and to a
lesser extent from residual oxygen in the plasma reactor.
Plasma processing occurs far from thermodynamic equilibrium, and
the results can often be explained in the light of kinetic arguments. In
this work, the treatments 1 and 2 differed in duration and power ap-
plied to the plasma. The fact that they nevertheless produced similar
XPS results suggests that after 60 s at 75W a situation of dynamic equi-
librium has been reached and the rate of nitrogen incorporation to the
PS surface from ions in the plasma is already the same as the rate of ni-
trogen removal due to the associated ion bombardment effect. In this
case, processing longer (and at higher power) simply results in addi-
tional erosion of the substrates without signiﬁcant changes in surface
composition.
As noted above, the surface composition of PS submitted to treat-
ments 1 and 2 was similar; even during the shelf life experiment
(Fig. 4). The signiﬁcant change in composition between preparation
(Day 0) and Days 15 and 30 could be accompanied by a signiﬁcantchange in performance regarding bacterial adhesion. An additional
physical property was searched aiming at increased correlation with
the bioassays.
3.4. Effects of plasma treatment on water contact angle
The polar component of the surface energy of PS, which is essentially
proportional to the abundance of polar (hydrophilic) species on the sur-
face, such as nitrogen-containing chemical moieties, is shown in Fig. 5.
Surface energy increased sharply with the application of plasma treat-
ment and then declined, as samples age. Surface energies resulting
from treatments 1 and 2 were similar within 5 mJ m−2 (ranging from
17 to 21 mJ m−2) with a minimum of 14 mJ m−2 for treatment 1
aged 30 days. The polar component for the pristine PS substrate never
exceeded 9 mJ m−2.
4. Discussion
Planktonic bacteria that attach to a surface and grow as a bioﬁlm
are protected from killing by antimicrobials, contributing to the persis-
tence of infections such as those associated withmedical implanted de-
vices [40]. In this context, the emergence and global spread of
carbapenemase-producing Enterobacteriaceae, such as Klebsiella spp.,
Enterobacter spp., Escherichia coli, and S. marcescens, pose an immediate
infection threat to vulnerable hospitalized patients and a potential
threat to individuals in general. Furthermore, long-lasting concerns
about Staphylococcus infections likewise persist, since they represent
frequent causes of nosocomial infections and infections on indwelling
medical devices [41,17].
This study focused on seven bacterial strains which are considered
highly relevant from the clinical point of view, since they presented
high level of resistance proﬁle to antimicrobials, according to the MIC
determined based on a panel of antimicrobial agents (Table 1). All
strains studied (E. cloacae, S.marcescens, MRSA and S. epidermidis), dem-
onstrated a strong ability to adhere and to form bioﬁlm on polystyrene,
except K. pneumoniae, which presented a moderate capacity to adhere
and to form bioﬁlm on this surface (Table 1). The exposure of PS to
N2/H2 plasma (treatments 1 and 2) inhibited bacterial adhesion of
strains that present hydrophilic surface (HBPI below 70%), reaching up
to 83% adhesion inhibition for K. pneumoniae, 77% for S. marcescens,
65% for S. aureus and 48% for E. cloacae, during the ﬁrst 24 h. Oppositely,
S. epidermidis, which present hydrophobic surfaces (HBPI above 70%),
retained its ability to adhere on the treated surfaces (Fig. 1). The results
of OD600 (Fig. 2) and resazurin evaluations revealed bacterial cell viabil-
ity of the planktonic cells in treated samples. Therefore, plasma treat-
ments are indeed inhibiting bacterial adhesion, not growth.
Bacterial adhesion is the ﬁrst step in bioﬁlm formation. The initial
adhesion process is inﬂuenced by bacterial features, by thematerial sur-
face properties and by the microenvironmental interactions [10]. In
order to explain the complex processes involved in adhesion and non-
adhesion mechanisms of bacteria on surfaces, some theories have
been proposed. Initial bacterial adhesion is governed by non-speciﬁc
interactions, and is commonly explained using the Derjaguin–Landau–
Verwey–Overbeek (DLVO) theory [42]. Brieﬂy, the classical DLVO
approach considers two additive forces: (i) an attractive van der Walls
interaction and (ii) a repulsive or attractive interaction, depending on
the surface charge of the substrate and on the electrostatic double
layer of the bacterial cell. This model is useful to describe qualitatively
the cell adhesion onto solid substrates, but its theoretical predictions
do not always elucidate biological phenomena observed [43–45]. The
thermodynamic approach considers the Gibbs energy involved in the
bacterial adhesion, but also fails to properly explain some results
[46,47]. Nowadays, themost promising theory, which uses components
from both models and includes distance dependent hydrophobicity/
hydration effects – the extended DLVO theory – has been successfully
applied to explain some bacterial behavior regarding adhesion [48,49].
Fig. 1. (a) Bacterial adhesion on plasma treated polystyrene. Bars represent percentagemean± standard deviation of three experiments in comparison to untreated samples (100%). TT 1
and TT 2 represent treatments 1 and 2, respectively. * statistical difference in comparison to the untreated samples for each bacterium; S. aureus: a— statistical difference from TT 1 Day 30
and b— from TT 2 Day 30; S. marcescens: c— statistical difference from TT 2 Day 0 and d— from TT 2 Day 30; E. cloacae: e— statistical difference from TT 1 Day 30 and f— from TT 1 Day 0;
S. epidermidis 122: g— statistical difference from TT 2 Day 0; S. epidermidis 167b: h— statistical difference fromTT 1Day 30. (b) Photos of crystal violet assay: bacterial adhesion on treated
PS (TT 1 — Day 0). (c) Schematic representation of the increasing HPBI values of the tested strains.
Fig. 2. Bacterial growth on plasma treated polystyrene. Bars present percentage mean ± standard deviation of three experiments in comparison to untreated samples (100%). TT 1 rep-
resents treatment 1 and TT 2 represents treatment 2. S. epidermidisATCC 35984: * statistical difference in comparison to the untreated samples and a— statistical difference from TT 2 Day
30; S. epidermidis 167b: b — statistical difference from TT 1 Day 0.
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Fig. 3. C 1s XPS spectra from pristine PS (control— solid triangles) and samples submitted
to plasma treatments 1 (TT 1— solid squares) and 2 (TT 2— open circles). Dashed line cor-
responds to the background and solid lines to spectral components that were used to ﬁt
experimental data. a.u. stands for arbitrary units.
Fig. 5. Polar energy of the PS surface as determined from water contact angle measure-
ments for samples submitted to treatment 1 (TT 1 — open square), treatment 2 (TT 2 —
solid square) and control sample (solid triangles). Lines are shown only to facilitate
visualization.
89D.S. Trentin et al. / Surface & Coatings Technology 245 (2014) 84–91Thereby, several surface properties, including roughness, wettability,
composition, electric charge, and surface free energy seem to contribute
in the complex mechanism of bacterial adhesion [10].
This work reports the composition and the polar component of sur-
face energy for plasma-treated PS. Previous plasma treatment experi-
ments (Supplementary data S1) indicated negligible roughness
(root mean square value in the nanometer range) and an essentially
constant dispersive component of surface energy. Data presented
herein show that both PSM treatments introduce nitrogen-containing
moieties at the PS surface (Fig. 4), increasing the polar component of
surface energy. Fig. 6(a) and (b) illustrates bacterial adhesion for PS sur-
faces submitted to treatments 1 and 2, respectively, as a function of the
bacterial hydrophobicity investigated in this work. It can be observed
that the higher the bacterial surface hydrophobicity, the higher the bac-
terial attachment, regardless the treatment (1 or 2). The fact that adhe-
sion of hydrophilic bacteria (HPBI below 70%) is suppressed more
effectively might be explained considering that the bacterial surface
and the PS substrate polarization is the same, i.e. charges due to
nitrogen-containing groups on PS and bacterial surface charge are of
the same type and thus lead to electrostatic repulsion. HydrophobicFig. 4.Nitrogen (squares) and oxygen (circles) surface abundances of plasma treated PS as
a function of shelf life for samples submitted to treatment 1 (TT 1— open symbols) treat-
ment 2 (TT2 — full symbols). Lines are only to guide the eyes.bacteria (HPBI above 70%) continue to adhere to the PS surface because
charges on the substrate induce opposite polarization in the bacteria, as
seen for S. epidermidis strains (Fig. 1). A schematic representation of the
above argument is presented in Fig. 6(c). Such reasoning does not de-
pend on particular properties of the biomaterial or bacteria utilized,
and so it should be a general rule that PSM of biomaterials using nitro-
gen either inhibits or promotes the adhesion of hydrophilic bacteria
(depending whether surface charges on the bacteria are of the same
or different types compared to the biomaterial surface), while hydro-
phobic bacteria are the least affected. Interestingly, another study dem-
onstrated that the surface hydrophobicity of S. epidermidis strains
presents large variations, varying from 3 to 89% using the MATH test
[50]. This ﬁnding could support the effectiveness of the plasma treat-
ments herein used against hydrophilic strains of S. epidermidis.
Beyond the qualitative discussion,we observed that surface nitrogen
concentrations in excess of 8.8% or polar component of the surface ener-
gy above 15 mJ m−2 are sufﬁcient to produce the beneﬁcial effects
sought. It has been reported that plasma inducedmodiﬁcations of poly-
mer surfaces can undergo changes with time after treatment [51]. Life-
timewill thus depend on how aggressive (chemically) is themedium in
which the biomaterial will be used or stored, and that, if known in ad-
vance, could be used to select between oxygen and nitrogen plasma
modiﬁcations for a given application. As it can be seen, experiments of
shelf life demonstrated that the surface properties of the PS start to de-
grade. A drop in nitrogen concentration (Fig. 4) for 15 and 30 days after
treatment and consequent reduction in the polar component of surface
energy (Fig. 5) were observed. Such aging has been attributed to the
combined effect of post-plasma treatment reactions (in this case, reac-
tions of nitrogen-containing moieties among themselves and with the
environment), polymer surface reorientation, and migration of short-
chain polymer fragments [52]. None of these individual mechanisms
can be ruled out based on the data from our experiments.
The control of bacterial attachment and bioﬁlm formation is very
complex, as demonstrated by the historical inability to produce clinical-
ly effective biomaterial implants resistant to infection [53]. This study
focuses on the applicability of non-thermal N2/H2 plasma to generate
anti-infective PS surfaces, but it is important to observe that the inhibi-
tion of bacterial adhesion obtainedwas not 100%. In this sense some as-
pects should be considered: (i) in a potential future application of these
surfaces in clinical settings, the insertion or incision procedures will
probably be accompanied by appropriate prophylactic antibiotic thera-
pies and; (ii) the total number of bacteria-laden particles related to pos-
sible contaminant microorganisms is much lower than the inoculum
Fig. 6. Bacterial adhesion as a function of bacterial hydrophobicity for bacterial strains on
plasma treated PS: (a) TT 1 (open circles) and (b) TT 2 (full squares). (c) Schematic dia-
gram of the (non)bacterial adhesion model based on the surface–bacteria polarization.
90 D.S. Trentin et al. / Surface & Coatings Technology 245 (2014) 84–91used in this study (1.5 × 108 CFUmL−1 in the wells). Indeed, the under-
standing and control of polymer–bacterium interactions may be more
complex when the formation of a conditioning ﬁlm is taken in account.
After implantation, a conditioning ﬁlm from organic matter present in
the host surrounding ﬂuidmay be deposited on the biomaterial surface.
The composition of this ﬁlm depends both on the material surface fea-
tures and the site body (tissue ﬂuid, saliva, urine, blood and serum),
and comprises mostly proteins, such as albumin, immunoglobulin, ﬁ-
brinogen and ﬁbronectin [54,55]. In this sense, current ﬁndings
are promising, since nitrogen-based plasma systems, such as N2, NH3,
Ar/NH3 and O2/NH3 have been used to produce hydrophilic surfaces
on different polymer substrates, such as polyethersulfone and polypro-
pylene membranes, in order to overcome protein fouling [56–58]. Theperformance of N2/H2 plasma processing-PS regarding bacterial adhe-
sion in the presence of the conditioning ﬁlm remains to be explored in
a further investigation.
5. Conclusions
This study presents N2/H2 plasma treatments that produce a much
less bacterial adherent and non-biocidal material, underlining plasma
technical applicability as a suitable clean and fast alternative processing
for medical polymermaterials. The correlation betweenmicrobiological
and physicochemical investigations demonstrated that bacteria pre-
senting hydrophilic surface (here exempliﬁed by KPC-producing En-
terobacteriaceae and MRSA) had adhesion signiﬁcantly inhibited on
treated PS surfaces. Experiments evaluating the shelf life of plasma-
treated PS indicated that the surface nitrogen concentration in excess
of 8.8 at.%, which was equivalent to polar component of the surface en-
ergy above 15 mJ m−2, is critical for limiting bacterial adhesion.
S. epidermidis hydrophobic strainswere not affected, allowing us to sug-
gest that these effects may be explained in terms of electrostatic repul-
sion. The heterogeneity and complexity of bacterial surfaces, including
the variability across different species and strains, contribute to the dif-
ﬁculty in generalizing ﬁndings considering the impairment of bacterial
attachment on substrata. Thereby, the potential application of a fast
technique, as PSM, extends the possibility of controlling the adhesion
of various bacterial species and genera, including clinically important
pathogens, since it does not target speciﬁc microbial structure or sub-
strate, unlike traditional antimicrobial agents. Moreover, compared to
the antimicrobial-based coating approach that kill microorganisms to
mitigate bacterial colonization, the PSM treatments presented in this
work would be associatedwithminimal development of bacterial resis-
tance, interfering just with bacterial surface–material surface interac-
tions. Regarding the dramatic situation in the hospital environment,
where the usual management to combat pathogenic bioﬁlms is the re-
moval of thousands of infected artiﬁcial devices, the results presented
herein should be considered as a clue and a contribution to explore
PSM methods for future material development.
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